Structure of the C2 domain of human factor VIII at 1.5 Å resolution

Nature

Volumn 402, Issue 6760, 1999, Pages 439-442

  Pratt, Kathleen P ^a,b   Shen, Betty W ^a   Takeshima, Kazuya ^b   Davie, Earl W ^b   Fujikawat, Kazuo ^b   Stoddard, Barry L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; HYDROPHOBICITY; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE;

CRYSTALLOGRAPHY, X-RAY; ELECTROCHEMISTRY; FACTOR VIII; HEMOPHILIA A; HUMANS; MODELS, MOLECULAR; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY;

EID: 0033604501     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/46601     Document Type: Article

References (30)

1. Kane, W. H. & Davie, E. W. Blood coagulation factors Vand VlII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71, 539-555 (1988).
2. Kaufman, R. J. Biological regulation of factor VIII activity. Annu. Rev. Med. 43, 325-339 (1992).
3. Fay, P. J., Coumans, J.-V. & Walker, F. J. Von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J. Biol. Chem. 266, 2172-2177 (1991).
4. Foster, P. A., Fulcher, C. A., Houghten, R. A. & Zimmerman, T. S. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 75, 1999-2004 (1990).
5. Duffy, E. J., Parker, E. T., Mutucumarana, V. P., Johnson, A. E. & Lollar, P. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles. J. Biol. Chem. 267, 17006-17011 (1992).
6. Duffy, E. J. & Lollar, P. Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191. J. Biol. Chem. 267, 7821-7827 (1992).
7. van Dieijen, G., Tans, G., Rosing, J. & Hemker, H. C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 156, 3433-3442 (1981).
8. Krishnaswamy, S., Nesheim, M. E., Prydzial, E. L. G. & Mann, K. G. Assembly of prothrombinase complex. Methods Enzymol. 222, 260-280 (1993).
9. Mann, K. G., Nesheim, M. E., Church, W. R., Haley, P. & Krishnaswamy, S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1-16 (1990).
10. Saenko, E. L. & Scandella, D. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J. Biol. Chem. 270, 13826-13833 (1995).
11. Takeshima, K. & Fujikawa, K. The phospholipid binding property of the C2 domain of human factor VIII. J. Biol Chem. (submitted).
12. Pellequer, J.-L., Gale, A. J., Griffin, J. H. & Getzoff, E. D. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol. Dis. 24, 448-461 (1998).
13. Baumgartner, S., Hofmann, K., Chiquet-Ehrismann, R. & Bucher, P. The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci. 7, 1626-1631 (1998).
14. Veeraraghavan, S., Baleja, J. D. & Gilbert, G. E. Structure and topography of the membrane-binding C2 domain of factor VIII in the presence of dodecylphosphocholine micelles. Biochem. J. 332, 549-555 (1998).
15. Gilbert, G. E. & Baleja, J. D. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. Biochemistry 34, 3022-3031 (1995).
16. Haemostasis Research Group at the MRC Clinical Sciences Centre, Imperial College Medical School. Haemophilia A mutation database. http://europium.mrc.rpms.ac.uk/HAMSterS:
17. Wolfenden, R., Andersson, L., Cullis, P. M. & Southgate, C. C. B. Affinities of amino acid side chains for solvent water. Biochemistry 20, 849-855 (1981).
18. Hoyer, L. W. & Scandella, D. Factor VIII inhibitors: structure and function in autoantibody and hemophila A patients. Semin. Hematol. 31 (Suppl. 4), 1-5 (1994).
19. Healey, J. F. et al. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII. Blood 92, 3701-3709 (1998).
20. Jacquemin, M. G. et al. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood 92, 496-506 (1998).
21. Kuwabara, I. et al. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients. J. Immun. Methods 224, 89-99 (1999).
22. Shima, M. et al. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb. Haemost. 69, 240-246 (1993).
23. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
24. Collaborative Computing Project 4. The CCP4 Suite: Programs for protein crystallography. Acta Cryst. D 50, 760-763 (1994).
25. LaFortelle, E., Irwin, J. J. & Bricogne, G. in Crystallographic Computing Vol. 7 (eds Bourne, P. & Watenpaugh, K.) 100-130 (Oxford Science Publications, Oxford, 1997).
26. Nieh, Y.-P. & Zhang, K. Y. J. A 2D histogram matching method for protein phase refinement and extension. Acta Crystallogr. D (in the press).
27. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
28. Brunger, A. T. et al. Crystallography and NMR System. Acta Crystallogr. D 44, 905-921 (1998).
29. Brunger, A. Assessment of phase accuracy by cross validation: the free R value. Methods and Applications. Acta Crystallogr. D 49, 24-36 (1993).
30. Laskowski, R. J., Macarthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-290 (1993).